Dr. Gian Luca Barbruni is the founding CEO of MoleSense. 

At MoleSense, he is building a gender-balanced team of visionary scientists with one clear mission: to transform maternity care. He is leading the development of the first molecular wearable for maternity management, capable to detect complications before symptoms appear—shifting maternal health from reactive to truly preventive.

Gian Luca Barbruni achieved his B.Sc. and M.Sc. in Biomedical Engineering at Politecnico di Torino, Italy in 2017 and 2019, respectively. He was a Research Assistant at the Department of Electronic Engineering (DET) of Politecnico di Torino. He obtained his Ph.D. degree in Microelectronics and Microsystems at EPFL, Switzerland in 2023, focusing on the design and development of ultra-miniaturised, wireless and implantable bioelectronics. During his postdoctoral studies he focused on designing novel circuital architectures for in-memory sensing and computing, and on drinkable µm-sized bioelectronics for enhanced brain imaging and for electrochemical sensing in precise diagnostics.

He authored and co-authored +15 refereed journal papers (IEEE TBCAS, IEEE SSC-M, IEEE TCAS-II, IEEE Sensors Journal, IEEE Sensors Letters, Elsevier Engineering), +20 peer-reviewed international conference papers and 3 PCT patents. He is a IEEE member and he serves as a reviewer for the IEEE Transactions of Biomedical Circuits and Systems, IEEE Transactions of Circuits and Systems, IEEE Sensors Journal. He serves as a TPC member for IEEE BioCAS (from 2021), IEEE Sensors (from 2021), IEEE MeMeA (from 2022), IEEE ICECS (from 2023).